EurekAlert!

MD Anderson and the Rare Cancer Research Foundation launch collaboration to accelerate the development of treatments for rare cancers

HOUSTON and DURHAM, N.C. ― The University of Texas MD Anderson Cancer Center and the Rare Cancer Research Foundation today announced the launch of a collaboration designed to accelerate the ...
Business Wire

Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

Multi-year collaboration will facilitate the co-development of optimized therapeutics that bind to challenging targets in ways traditional techniques cannot SOMERVILLE, Mass. & HOUSTON--(BUSINESS WIRE ...
GEN

Generate:Biomedicines and MD Anderson Sign AI-Driven Protein Therapeutics for Cancer Deal

Generate:Biomedicines and the University of Texas MD Anderson Cancer Center agreed to jointly discover and co-develop protein therapeutics for up to five oncology targets in advanced cancers, ...
Business Wire

Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

“ Together with Generate:Biomedicines, we aim to leverage rapid advancements in generative AI to develop new medicines that are purpose-built for those who do not benefit from existing treatments or ...